Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country

por How, Soon Hin, Tho, Lye Mun, Liam, Chong Kin, Hasbullah, Harissa H., Ho, Gwo Fuang, Muhammad Nor, Ibtisam, Poh, Mau Ern, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Pang, Yong Kek, Soon, Sing Yang
Publicado 2022

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country

por Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H, Tho, Lye Mun, Muhamad Nor, Ibtisam, Lim, Bee Chiu, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Tan, Justin Yu Kuan, Zainal Abidin, Muhammad Adil
Publicado 2023

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

por How, Soon Hin, Liam, Chong Kin, Zainal Abidin, Muhammad Adil, Hasbullah, Harissa H, Tho, Lye Mun, Ho, Gwo Fuang, Muhamad Nor, Ibtisam, Pang, Yong Kek, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Ariffin, Roziana, Samsudin, Azlina, Omar, Azza, Tan, Sin Nee, Ong, Choo Khoon, Soon, Sing Yang, Poh, Mau Ern
Publicado 2022